1 study found for:    bREAST NSABP B-43
Show Display Options
Rank Status Study
1 Active, not recruiting Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Ductal Breast Carcinoma In Situ;   HER2/Neu Positive
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Trastuzumab;   Radiation: Whole Breast Irradiation

Indicates status has not been verified in more than two years